PT-141

Steady

PT-141 appears in 135 indexed publications going back to 1995, including 11 in the past twelve months. 10 registered trials appear on ClinicalTrials.gov.

135

Indexed publications

Past 12 months, against 11 the year before

Registered clinical trials

6,200

Monthly readers on Wikipedia, down 15%

Research Activity

Publication history

How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.

20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
2015	2
2016	2
2017	7
2018	4
2019	8
2020	7
2021	9
2022	13
2023	6
2024	5
2025	11
2026	10

Public Attention

Who is looking it up

Monthly readers of the PT-141 article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.

2025-082026-07

Clinical Trials

The registered pipeline

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase distribution across the most recently updated registered trials.

Completed·Phase 4
Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk
Cosette Pharmaceuticals, Inc. · completed 2025-11-15
Active, not recruiting·Phase 2
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
Palatin Technologies, Inc · completed 2025-02-05
Completed·Phase 3
A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)
Kwang Dong Pharmaceutical co., ltd. · completed 2023-05-16
Completed·Phase 2
A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
Palatin Technologies, Inc · completed 2024-04-26
Completed·Phase 4
Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder
Imperial College Healthcare NHS Trust · completed 2020-10-06
Completed·Phase 1
Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran
AMAG Pharmaceuticals, Inc. · completed 2019-07-19

References

Most recent work

The newest indexed records mentioning PT-141, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.

2026-07-22·Analytical methods : advancing methods and applications
Comprehensive characterization of bremelanotide acetate and its degradants by LC-HRMS/MS and predicting epimerization through computational modelling
Yuvaraaj VK, Sharma N. et al.
2025-12-17·Journal of minimally invasive gynecology
Strategies for Treating Sexual Health Concerns After Breast and Gynecologic Cancer
Mihulka O, Curran M, Narasimhan RM et al.
2026-06-24·Journal of medicinal chemistry
Goldilocks-Inspired Design of Mid-Size Macrocycles for Selective Targeting of Human Melanocortin Receptors
Merlino F, Jia L, Boccino I et al.
2026-05-01·Drug development research
FDA-Approved Drugs Containing D-Amino Acids: A Historical and Developmental Perspective
Tran L, Nguyen TD, Gad AG et al.
2026-04-10·Journal of clinical psychopharmacology
Should Bremelanotide Be Considered for the Treatment of Sexual Arousal and Desire Disorders in Men?
Pfaus JG, Balon R. et al.
2026-05-22·Frontiers in medicine
Clinical trial evidence on emerging pharmacological therapies for hypoactive sexual desire disorder in women: a systematic review and analysis of completed studies registered on ClinicalTrials.gov
Ashour AM. et al.
2026-05-18·Journal of sex & marital therapy
Quantification of "Mercy Sex" in Heterosexual Women
Guptan N, Simon JA. et al.
2026-04-07·Frontiers in aging
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Mavrych V, Shypilova I, Bolgova O. et al.

In the Catalogue

PT-141 available from Polaris Research

PT-141 10mg

Hormonal & Libido

$0.89View product

Supplied as research materials for laboratory use. Free express delivery Australia wide.

Sources

Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-08-02.